PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease ReportsCardiogenic shock
MeSH D012770 - cardiogenic shock
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D009203:Myocardial infarction
172 Companies
45 Drugs
$
Success rate
D012769:Shock
92 Companies
18 Drugs
$
Success rate
D012770: 
Cardiogenic shock
24 Companies
4 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Eli LillyGlucagon Baqsimi  2019-12-16 $652.8 M Q2/23-Q3/24 
Glucagon Glucagon  1982-01-01   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
80%
4/5
Phase 3
47%
7/15
Approved: 4Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
GSK
Digoxin
Eli Lilly
Glucagon,
Clotinab,
Arm1,
Bolus
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use